SCOTTSDALE, AZ--(Marketwire - November 06, 2008) - ImmuneRegen BioSciences, Inc., a development-stage biotechnology company and wholly owned subsidiary of IR BioSciences Holdings, Inc. (OTCBB: IRBS), will present at the Rodman & Renshaw 10th Annual Global Healthcare Conference, Nov. 10 - 12, in New York City. Michael Wilhelm, president and CEO of ImmuneRegen, and the Company’s key science directors will speak on Nov. 10th at 12:25 p.m. EST and will then be available to meet with potential investors and industry analysts. The presentation will focus on the investment opportunity surrounding the Company’s compound, Homspera®, an adult stem cell active peptide that has been shown in preclinical studies to regenerate and strengthen the immune system, as well as enhance wound healing. Wilhelm and his team will also provide an update on the Company’s product pipeline and showcase its partnerships with industry and academic leaders.
